Deputy Chief Pharmacist | Xijing Hospital of Air Force Medical University | China
Shanbo Ma is a dedicated researcher in the field of Chinese pharmacology, focusing on the pharmacological mechanisms and therapeutic potential of traditional Chinese medicine (TCM). With a strong academic background and extensive research experience, he has contributed significantly to the study of anti-inflammatory effects and active ingredients in TCM. His expertise spans molecular biology, cell biology, and bioinformatics, making him a key figure in integrating computational and experimental approaches to drug discovery.
Professional profile👤
Scopus
Strengths for the Awards✨
-
Strong Research Output & Impact 📚
- Published multiple peer-reviewed articles in high-impact journals such as Frontiers in Pharmacology, Journal of Ethnopharmacology, and Journal of Biomolecular Structure & Dynamics.
- Research spans diverse pharmacological applications, including colorectal cancer, anxiety treatment, ulcerative colitis, and depression, indicating a broad impact in Chinese pharmacology and molecular medicine.
- Co-first and co-corresponding authorships in multiple papers highlight leadership in research projects.
-
Interdisciplinary Expertise 🔬
- Skilled in network pharmacology, molecular docking, bioinformatics, and experimental validation, demonstrating a strong foundation in both computational and experimental pharmacology.
- Expertise in cell biology, molecular biology, and animal experiments, which are critical for translational research in pharmacology.
-
Technical & Analytical Proficiency 💻
- Proficient in essential research tools, including GraphPad, Cytoscape, Photoshop, SYBYL, and Image J, supporting advanced data analysis and visualization.
-
Recognition & Awards 🏆
- Received the Outstanding Paper Award (2023) from the Chinese Pharmaceutical Society, a significant achievement showcasing research excellence.
-
Educational Background & Training 🎓
- Holds a Ph.D. in Science of Chinese Pharmacology from Northwest University (2020–2024).
- Completed a Master’s in Chinese Medicine from Shaanxi University of Chinese Medicine and a Bachelor’s in Pharmacology from Bengbu Medical University, providing a solid academic foundation.
🎓 Education
- 📌 2020.09 – 2024.06 | Northwest University | Doctorate in Science of Chinese Pharmacology
- 📌 2014.09 – 2017.07 | Shaanxi University of Chinese Medicine | Master’s in Chinese Medicine
- 📌 2013.09 – 2017.07 | Bengbu Medical University | Bachelor’s in Pharmacology
💼 Experience
Shanbo Ma has been actively involved in pharmacological research, specializing in the bioactivity screening and mechanistic exploration of TCM. His work integrates network pharmacology, bioinformatics, and molecular docking techniques to elucidate drug mechanisms. He has also demonstrated proficiency in project design and team coordination, leading multiple research initiatives and collaborations.
- Screening the pharmacological substance basis of traditional Chinese medicine
- Investigating the anti-inflammatory effects and mechanisms of TCM and its active ingredients
- Utilizing bioinformatics and network pharmacology to analyze drug-target interactions
- Exploring molecular docking and experimental validation methods for TCM efficacy
🏆 Awards
- 🏅 Outstanding Paper Award, Chinese Pharmaceutical Society (2023)
📚 Publications
-
Elucidation of the mechanism of action of ailanthone in the treatment of colorectal cancer: integration of network pharmacology, bioinformatics analysis and experimental validation
- Authors: Ma Shanbo, Guo Xiaodi, et al.
- Publication Year: 2024
-
Glycyrrhizic acid treatment ameliorates anxiety-like behaviour via GLT1 and Per1/2-dependent pathways
- Authors: Ma Shanbo, Chong Ye, et al.
- Publication Year: 2024
-
Virtual screening-molecular docking-activity evaluation of Ailanthus altissima (Mill.) swingle bark in the treatment of ulcerative colitis
- Authors: Ma Shanbo, Liu Lun, et al.
- Publication Year: 2023
-
Investigating the mechanism of Sinisan formula in depression treatment: a comprehensive analysis using GEO datasets, network pharmacology, and molecular docking
- Authors: Zheng Meiling, Yang, Shi Xiaopeng#, Ma Shanbo#
- Publication Year: 2024
-
Network pharmacology and molecular docking to study the potential molecular mechanism of Qi Fu Yin for diabetic encephalopathy
- Authors: Guo Xiaodi, Wang Feiyan, Ma Shanbo#, Shi Xiaopeng#
- Publication Year: 2023
-
Investigation into the in vivo mechanism of diosmetin in patients with breast cancer and COVID-19 using bioinformatics
- Authors: Wang Jin*, Ma Shanbo*, et al.
- Publication Year: 2022
🔬 Skills
- Expertise in cell biology, molecular biology, and animal experiments
- Proficient in bioinformatics tools such as GraphPad, AI, Photoshop, ImageJ, Cytoscape, and SYBYL
- Strong ability to design projects independently and coordinate teamwork
🔚 Conclusion
Shanbo Ma is a passionate and accomplished researcher in Chinese pharmacology, making substantial contributions to understanding the therapeutic mechanisms of traditional medicines. His expertise in network pharmacology, molecular docking, and bioinformatics enhances his ability to uncover novel insights in drug discovery. With numerous publications and an award-winning research portfolio, he continues to drive advancements in the field of traditional medicine research.
